or
forgot password

The Elizabeth Registry for Low Grade Ovarian Cancer


N/A
N/A
N/A
Open (Enrolling)
Female
Ovarian Cancer

Thank you

Trial Information

The Elizabeth Registry for Low Grade Ovarian Cancer


The Registry will be an ongoing research registry that will include patients who have been
diagnosed with low grade ovarian, primary peritoneal or fallopian tube or low malignant
potential (LMP) ovarian, primary peritoneal or fallopian tube cancer.

In order to enroll in the Registry, you will be asked to complete a 65 page questionnaire
that contains questions about your ovarian cancer diagnosis, gynecologic history, family
history, general medical history, and health risk factors. This questionnaire will take
about 1 hour to complete.

In addition, researchers will look at your medical record and pathology samples stored at M.
D. Anderson to get information about your surgeries, treatments, disease course, and tumor
grade. If your original surgery was not performed at M. D. Anderson, you may be asked to
provide tumor specimens from that surgery before enrolling in the Registry.

You will be contacted annually by the Registry Coordinator to update your demographic and
health information.

This is an investigational study. The Registry will eventually enroll both M. D. Anderson
and non-M. D. Anderson patients. The number of registrants is unlimited because the Registry
will be ongoing. This study is partially funded by a research grant from the Elizabeth Fund
for the Study of Low Grade Ovarian Carcinoma.


Inclusion Criteria:



1. UTMDACC patient, living or deceased, with a pathologically-confirmed diagnosis of
either low grade ovarian carcinoma or LMP ovarian carcinoma.

2. Able to speak and read English (for patients who are living).

3. Residence in the United States, both at time of original diagnosis and at time of
accession to the Registry.

Exclusion Criteria:

1. UTMDACC patients, living or deceased, whose diagnosis of either low grade ovarian
carcinoma or LMP ovarian carcinoma has not been confirmed pathologically.

2. Any type of ovarian cancer other than low grade or LMP ovarian carcinoma.

3. Unable to speak and read English (for patients who are living).

4. Residence outside the United States, either at time of original diagnosis or at time
of accession to the Registry.

Type of Study:

Observational

Study Design:

Observational Model: Case-Only

Outcome Measure:

Establish an ongoing national research registry of epidemiologic, clinical and pathologic data on low grade and low malignant potential (LMP) ovarian cancer patients in UTMDACC's Department of Gynecologic Oncology for research purposes.

Outcome Time Frame:

30 Years

Safety Issue:

No

Principal Investigator

Diane C. Bodurka, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

M.D. Anderson Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

2003-0359

NCT ID:

NCT00345709

Start Date:

September 2003

Completion Date:

Related Keywords:

  • Ovarian Cancer
  • Ovarian Cancer
  • Peritoneal Cancer
  • Fallopian Tube Cancer
  • Elizabeth Registry
  • Questionnaire
  • Registry
  • Survey
  • Ovarian Neoplasms

Name

Location
UT MD Anderson Cancer Center Houston, Texas  77030